Elizabeth Anderson

Q: What is Elizabeth Anderson's success rate?

Elizabeth Anderson currently has a success rate of 93.20365445791268.

Q: What is the average return of Elizabeth Anderson's calls?

Their stock ratings have generated an average return of 15.355727900377076.

Evercore ISI Group | Healthcare

Elizabeth Anderson is an analyst from Evercore ISI Group specializing in the Healthcare sector. Ranked #1294 out of 4673 analysts, they have issued 67 stock ratings with a success rate of 93.20% and an average return of 15.36%.

Elizabeth Anderson has a well-established track record, with 67 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 93.20% and an average return of 15.36%, underscoring their expertise and ability to identify winning opportunities for investors.

#1294

Out of 4673

Total Ratings

+93.20%

Success Rate

+15.36%

Average Return

Recent Ratings Analysis

GMRS

Buy

Jun 08, 2026

Target

$20.00

Current

$10.58

Performance

0.00%

Elizabeth Anderson rated GMRS as Outperform on Jun 08, 2026, setting a price target of 20. Shares have remained stable near 10.58, leaving the 20 target still in play.

MCK

Buy

May 08, 2026

Target

$850.00

Current

$766.64

Performance

4.15%

On May 08, 2026, MCK was given a Outperform rating by Elizabeth Anderson, with a target price of 850. The stock traded sideways with a 4.15% move, keeping the bullish thesis unresolved.

OMDA

Buy

May 08, 2026

Target

$20.00

Current

$17.88

Performance

20.65%

OMDA received a Outperform rating from Elizabeth Anderson on May 08, 2026, aiming for 20. Momentum has favored the Buy call, with shares climbing from 17.88 to 17.88, rewarding those who trusted the recommendation.

NVST

Buy

May 07, 2026

Target

$33.00

Current

$23.44

Performance

-3.50%

On May 07, 2026, Elizabeth Anderson published a Outperform outlook on NVST, with a target of 33. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 23.44.

CVS

Buy

May 07, 2026

Target

$105.00

Current

$97.08

Performance

11.13%

Elizabeth Anderson on May 07, 2026 assigned CVS a Outperform rating, with a price target of 105. The Buy call aligned well with market performance, producing a gain of 11.13%.

AGL

Hold

May 07, 2026

Target

$32.00

Current

$95.33

Performance

57.15%

On May 07, 2026, Elizabeth Anderson reaffirmed AGL with a In-Line rating, targeting 32. Market strength beyond 95.33 went further than the conservative outlook suggested.

ALGN

Buy

Apr 30, 2026

Target

$220.00

Current

$172.05

Performance

-2.25%

ALGN was rated Outperform by Elizabeth Anderson on Apr 30, 2026, with a price objective of 220. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

ELV

Hold

Apr 23, 2026

Target

$360.00

Current

$418.15

Performance

20.75%

On Apr 23, 2026, Elizabeth Anderson initiated coverage on ELV with a In-Line rating and target of 360. The Hold stance underestimated the stock’s strength as it gained 20.75%.

PRVA

Buy

Apr 08, 2026

Target

$26.00

Current

$21.41

Performance

-5.72%

Elizabeth Anderson issued a Outperform recommendation for PRVA on Apr 08, 2026, price target set at 26. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

TDOC

Hold

Apr 08, 2026

Target

$6.00

Current

$7.08

Performance

34.35%

On Apr 08, 2026, TDOC was evaluated by Elizabeth Anderson, who gave a In-Line rating and target of 6. Investors who stayed in despite the Hold saw upside of 34.35%.

IQV

Buy

Apr 08, 2026

Target

$185.00

Current

$183.69

Performance

6.46%

Elizabeth Anderson rated IQV as Outperform on Apr 08, 2026, setting a price target of 185. The call has proven timely, with shares rising 6.46% toward the price target of 185.

DOCS

Hold

Apr 08, 2026

Target

$25.00

Current

$20.30

Performance

-7.14%

On Apr 08, 2026, DOCS was given a In-Line rating by Elizabeth Anderson, with a target price of 25. The rating provided protection from downside risk as the stock fell to 20.3.

CAH

Buy

Apr 08, 2026

Target

$240.00

Current

$204.48

Performance

-4.95%

CAH received a Outperform rating from Elizabeth Anderson on Apr 08, 2026, aiming for 240. Price action was muted, as shares hovered around 204.48 despite the bullish outlook.

DGX

Hold

Apr 08, 2026

Target

$210.00

Current

$197.21

Performance

-0.80%

On Apr 08, 2026, Elizabeth Anderson published a In-Line outlook on DGX, with a target of 210. Sideways action left the Hold view intact, with no major move since 197.21.

FTRE

Buy

Apr 08, 2026

Target

$14.00

Current

$16.57

Performance

72.07%

Elizabeth Anderson on Apr 08, 2026 assigned FTRE a Outperform rating, with a price target of 14. The Buy call aligned well with market performance, producing a gain of 72.07%.

HNGE

Buy

Apr 08, 2026

Target

$45.00

Current

$62.86

Performance

64.17%

On Apr 08, 2026, Elizabeth Anderson reaffirmed HNGE with a Outperform rating, targeting 45. The recommendation was supported by strong follow-through as the stock rose from 62.86 to 62.86.

HSIC

Buy

Apr 08, 2026

Target

$90.00

Current

$78.05

Performance

3.34%

HSIC was rated Outperform by Elizabeth Anderson on Apr 08, 2026, with a price objective of 90. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

LH

Buy

Apr 08, 2026

Target

$300.00

Current

$262.01

Performance

-4.63%

On Apr 08, 2026, Elizabeth Anderson initiated coverage on LH with a Outperform rating and target of 300. Neutral price movement of -4.63% leaves room for interpretation.

XRAY

Hold

Feb 27, 2026

Target

$15.00

Current

$10.26

Performance

-30.11%

Elizabeth Anderson issued a In-Line recommendation for XRAY on Feb 27, 2026, price target set at 15. Market action validated the conservative Hold outlook with shares at 10.26.

MDLN

Buy

Feb 26, 2026

Target

$55.00

Current

$33.80

Performance

-30.87%

On Feb 26, 2026, MDLN was evaluated by Elizabeth Anderson, who gave a Outperform rating and target of 55. Investors saw limited payoff as shares fell short of the 55 target.

WAY

Buy

Feb 18, 2026

Target

$40.00

Current

$18.98

Performance

-25.30%

Elizabeth Anderson rated WAY as Outperform on Feb 18, 2026, setting a price target of 40. The stock has underperformed, dropping 25.30% despite the bullish target of 40.

HCAT

Hold

Oct 08, 2025

Target

$3.00

Current

$1.75

Performance

-38.77%

On Oct 08, 2025, HCAT was given a In-Line rating by Elizabeth Anderson, with a target price of 3. The rating provided protection from downside risk as the stock fell to 1.745.

WBA

Hold

Jan 13, 2025

Target

$12.00

Current

$11.98

Performance

0.67%

WBA received a In-Line rating from Elizabeth Anderson on Jan 13, 2025, aiming for 12. Shares remained flat at 11.98, aligning with the neutral rating.

Frequency Asked Questions

Who is Elizabeth Anderson?

Elizabeth Anderson is an analyst from Evercore ISI Group specializing in the Healthcare sector.

What is Elizabeth Anderson's success rate?

Elizabeth Anderson currently has a success rate of +93.20%.

How many ratings has Elizabeth Anderson issued?

Elizabeth Anderson has issued 67 stock ratings so far.

What is the average return of Elizabeth Anderson's calls?

Their stock ratings have generated an average return of +15.36%.

What is Elizabeth Anderson's ranking?

Elizabeth Anderson is ranked #1294 out of 4673 analysts.

What types of ratings does Elizabeth Anderson give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Elizabeth Anderson?

You can follow Elizabeth Anderson by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Elizabeth Anderson?

Their latest rating was a Buy on GMRS issued on 2026-06-08.